AzTrials
AzTrials

Magnetic Resonance ImagingCINEDLNCT05105984

Evaluation of a Free-breathing Cardiac Cine-MRI Sequence With Image Reconstructions by Deep-Learning in Ischemic Heart Disease

An observational study of Magnetic Resonance Imaging and Cardiac Magnetic Resonance Imaging, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Today, MRI is the gold standard for the precise assessment of left ventricular volume and function, but presents the drawback of having a long acquisition time and of generating motion artifacts, in particular respiratory artifacts, requiring repeated sequences in apnea to cover the whole cardiac volume. Read more about this study

Who is it for?
Ages 18 years and older
How many people
54 participants
Where
1 siteFrance
Study dates
14 Apr 2022to 29 Jan 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Cardiac MRI is one of the examinations prescribed as part of routine care for this pathology. When the patient come for a cardiac MRI in the workup for ischemic heart disease, the patient will be asked on the day of the exam if he agrees to participate in the study. An information letter will have been sent to the patient before the appointment is made. In the event that he agrees to participate, a free-breathing cardiac cine-MRI sequence with Deep Learning based image reconstruction will be appended to the usual protocol.

Who may be able to join

  • Age > or = 18 years old
  • Ischemic heart disease
  • Ability of the subject to understand and express his consent
  • Affiliation to the social security scheme

Who cannot join

  • Major obesity (> 140kg) not allowing the patient to enter the tunnel of the machine whose diameter is less than 70cm
  • Under 18 years old
  • Pregnant woman
  • Known allergy to gadolinium chelates
  • Claustrophobia
  • Any contraindication to MRI
  • Arrhythmia
  • Difficulty in holding apneas of more than 10 seconds

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Amiens-Picardie

    Amiens, France, 80000

Other trials in France

About this study

Official title: Evaluation of a Free-breathing Cardiac Cine-MRI Sequence With Image Reconstructions Developed by Deep-Learning Compared to the Classic Apnea Cine-MRI Sequence in the Assessment of Ischemic Heart Disease.

Today, MRI is the gold standard for the precise assessment of left ventricular volume and function, but presents the drawback of having a long acquisition time and of generating motion artifacts, in particular respiratory artifacts, requiring repeated sequences in apnea to cover the whole cardiac volume. These apneas are difficult to achieve in patients with ischemic heart disease and may lead to degradation of the images, an increase in the duration of the examination by repeated acquisitions and therefore to diagnostic inaccuracies.

Artificial intelligence, already used in practice in cardiac MRI for automatic segmentation of the heart chambers, improves radiological interpretation with rapid and precise measurements. Deep-learning, which is part of artificial intelligence, would allow the reconstruction of cine-MRI sequences in free breathing, in order to overcome the artifacts from respiratory motions, and the improvement of diagnostic performance while improving examination conditions for patients.

Read more

Patients coming for a cardiac MRI for the assessment of ischemic heart disease will be eligible to the protocol. If the patient agrees to participate, a free-breathing cardiac cine-MRI sequence with Deep Learning based image reconstruction will be added to the usual protocol.

No follow-up will be required in this study.

Keywords
Magnetic resonance imaging, Cardiac magnetic resonance imaging, Deep-Learning, Left ventricular ejection fraction, Left ventricular end systolic volume, left ventricular end diastolic volume

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. difference of LVEF measurements between Deep Learning reconstruction and the classic cine-MRI sequence

    difference of LVEF measurements between Deep Learning reconstruction and the classic cine-MRI sequence

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Nov 2021
  2. Study start14 Apr 2022
  3. Primary completion24 Apr 2023
  4. Study completion29 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
54 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05105984
Sponsor's protocol ID
PI2021_843_0157
Acronym
CINEDL
Status last verified
Nov 2025
First submitted
2 Nov 2021
Last updated
19 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Monteuuis D, Bouzerar R, Dantoing C, Poujol J, Bohbot Y, Renard C. Prospective Comparison of Free-Breathing Accelerated Cine Deep Learning Reconstruction Versus Standard Breath-Hold Cardiac MRI Sequences in Patients With Ischemic Heart Disease. AJR Am J Roentgenol. 2024 May;222(5):e2330272. doi: 10.2214/AJR.23.30272. Epub 2024 Feb 7.

    PubMed 38323784

Questions about this trial

What is this clinical trial studying?

An observational study of Magnetic Resonance Imaging and Cardiac Magnetic Resonance Imaging, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

difference of LVEF measurements between Deep Learning reconstruction and the classic cine-MRI sequence (time frame: 5 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05105984, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in